MA14.10 QTc Interval-Prolonging Medications in Lung Cancer: Implications for Clinical Trial Eligibility and Routine Clinical Care

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.437
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Low Utilization of Obesity Medications: What Are the Implications for Clinical Care?

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2016English

Preoperative High-Intensity Interval Training Is Effective and Safe in Deconditioned Patients With Lung Cancer: A Randomized Clinical Trial

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2019English

Racial Differences in Eligibility and Enrollment in a Smoking Cessation Clinical Trial.

Health Psychology
MedicinePsychiatryMental HealthApplied Psychology
2011English

Impact of Prior Malignancies on Outcome of Colorectal Cancer; Revisiting Clinical Trial Eligibility Criteria

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Metastatic Non-Small Cell Lung Cancer in Brazil: Treatment Heterogeneity in Routine Clinical Practice

Clinics
Medicine
2007English

A Joint Test for Progression and Survival With Interval-Censored Data From a Cancer Clinical Trial

Statistics in Medicine
EpidemiologyStatisticsProbability
2014English

Clinical Implications in Testicular Cancer

2018English

Promotion of Self-Care in Clinical Practice: Implications for Clinical Supervision in Nursing

International Journal of Information and Education Technology
Computer Science ApplicationsEducation
2015English

Clinical Research Protocols for Lung Cancer

Cancer Control
MedicineOncologyHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy